Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 0.97% | 275.52k | 89.82k |
Vanguard Extended Market Index Fund | 0.71% | 203.36k | 66.29k |
Fidelity Extended Market Index Fund | 0.26% | 73.97k | 24.11k |
iShares Micro Cap ETF | 0.11% | 32.54k | 10.61k |
Fidelity Series Total Market Index Fund | 0.08% | 23.94k | 7.8k |
Fidelity NASDAQ Composite Index Fund | 0.06% | 16.55k | 5.39k |
Fidelity Total Market Index Fund | 0.04% | 12.77k | 4.16k |
EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 2.34k | 761 |
Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight
04/28 01:00 pm
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04
02/25 10:00 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
01/29 10:00 am
GlobeNewswire Inc.
Read moreAlcohol Use Disorder Market Set for Remarkable Growth During the Study Period (2020–2034) | DelveInsight
12/11 02:00 pm
GlobeNewswire Inc.
Read moreEXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder - Benzinga
07/23 08:00 am
Benzinga
Read moreAdial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder
06/20 08:30 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
05/15 08:30 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
04/22 08:30 am
GlobeNewswire Inc.
Read moreS&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings
04/10 02:34 pm
Benzinga
Read moreDow Falls Over 1%; US Inflation Rate Accelerates In March
04/10 10:20 am
Benzinga
Read moreAdial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
04/10 08:30 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
04/02 08:30 am
GlobeNewswire Inc.
Read moreIs Masimo (MASI) Outperforming Other Medical Stocks This Year?
03/11 09:40 am
Zacks Investment Research
Read moreFinding Long Term Penny Stocks Investments? 3 Tips
03/04 07:51 am
PennyStocks
Read moreTop Habits Penny Stocks Traders Need to Follow
03/02 07:18 am
PennyStocks
Read moreAdial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
03/01 08:00 pm
GlobeNewswire Inc.
Read moreUS Stocks Mixed; Dell Posts Upbeat Results
03/01 10:47 am
Benzinga
Read moreWhat Trends Are Causing Penny Stocks to Move in 2024?
03/01 07:26 am
PennyStocks
Read moreTips for Understanding Penny Stocks Fundamentals
02/29 07:23 am
PennyStocks
Read moreS&P 500 Edges Lower; ADT Posts Upbeat Earnings
02/28 03:30 pm
Benzinga
Read moreNasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
02/28 01:25 pm
Benzinga
Read moreDow Dips 200 Points; TJX Posts Upbeat Sales
02/28 11:12 am
Benzinga
Read moreAdial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
02/28 10:30 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
02/13 10:15 am
GlobeNewswire Inc.
Read moreAdial Announces Appointment of Tony Goodman as Chief Operating Officer
01/18 09:30 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Receives Final Reimbursement Payment from Adovate
12/20 10:00 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement
11/29 05:05 pm
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
11/14 06:02 pm
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference
10/31 08:30 am
GlobeNewswire Inc.
Read moreAll You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
10/30 12:00 pm
Zacks Investment Research
Read moreAdial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
10/24 04:30 pm
GlobeNewswire Inc.
Read moreNasdaq Down Over 1%; Autoliv Raises FY23 Sales Outlook
10/20 02:42 pm
Benzinga
Read moreDow Falls 50 Points; American Express Earnings Top Views
10/20 09:43 am
Benzinga
Read moreAdial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
10/20 08:00 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence
10/19 10:30 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award
10/18 08:00 am
GlobeNewswire Inc.
Read moreAdial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder
09/28 07:00 am
GlobeNewswire Inc.
Read more